Dr. Mark D. Borchelt, MD, FACE
Endocrinology & Diabetes (Endocrinology, Diabetes & Metabolism Physician)
4540 W Railroad St
Gulfport, MS 39501
Who else practices at this address →
Harrison County is a federal mental health shortage area. About shortage areas
- Medicare participating
At a glance
- Medical school
- Northeastern Ohio University College of Medicine (1983)
- Years since graduation
- 43
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 728
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1983Medical school: Northeastern Ohio University College of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Endocrinology, Diabetes & Metabolism Physician primary
MS license 24066 · FL license ME62666
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Memorial Hospital at Gulfport Gulfport, MS
- Singing River Gulfport Gulfport, MS
Medical groups
- Memorial Hospital at Gulfport (474 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 728
- Services billed
- 2,269
- Patients’ average age
- 73
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 20-29 minutes | 670 | 524 |
| Established patient office or other outpatient visit, 30-39 minutes | 541 | 286 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 97 | 47 |
| New patient office or other outpatient visit, 30-44 minutes | 60 | 60 |
| New patient office or other outpatient visit, 45-59 minutes | 56 | 56 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Levothyroxine Sodium Other prescribers in Gulfport, MS | 788 |
| Mounjaro (tirzepatide) Other prescribers in Gulfport, MS | 701 |
| Ozempic (semaglutide) Other prescribers in Gulfport, MS | 556 |
| Jardiance (empagliflozin) Other prescribers in Gulfport, MS | 502 |
| Rosuvastatin Calcium Other prescribers in Gulfport, MS | 355 |
| Tresiba Flextouch U-200 (insulin degludec) Other prescribers in Gulfport, MS | 345 |
| Trulicity (dulaglutide) Other prescribers in Gulfport, MS | 320 |
| Metformin Hcl Other prescribers in Gulfport, MS | 292 |
| Synthroid (levothyroxine sodium) Other prescribers in Gulfport, MS | 235 |
| Pioglitazone Hcl Other prescribers in Gulfport, MS | 210 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 29 companies reported 278 payments worth $62,572 in total to this clinician.
| Lilly USA, LLC | $42,833 |
|---|---|
| Amgen Inc. | $9,023 |
| Bayer HealthCare Pharmaceuticals Inc. | $7,645 |
| Abbott Laboratories | $758 |
| Novo Nordisk Inc | $368 |
| Xeris Pharmaceuticals, Inc. | $270 |
| Medtronic, Inc. | $261 |
| Dexcom, Inc. | $229 |
| Compensation for services other than consulting (speaking, faculty) | $49,776 |
|---|---|
| Travel and Lodging | $7,188 |
| Food and Beverage | $5,568 |
| Education | $39.96 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Amgen Inc. May 1, 2025 | Compensation for services other than consulting (speaking, faculty) EVENITY · Bone Health | $3,200 |
| Lilly USA, LLC Feb 14, 2025 | Compensation for services other than consulting (speaking, faculty) MOUNJARO · Diabetes | $2,800 |
| Bayer HealthCare Pharmaceuticals Inc. Oct 8, 2025 | Compensation for services other than consulting (speaking, faculty) Kerendia · Cardio-Renal | $2,558 |
| Amgen Inc. Sep 24, 2025 | Compensation for services other than consulting (speaking, faculty) EVENITY · Bone Health | $2,400 |
| Lilly USA, LLC Mar 24, 2025 | Compensation for services other than consulting (speaking, faculty) MOUNJARO · Diabetes | $1,400 |
| Lilly USA, LLC Oct 23, 2025 | Compensation for services other than consulting (speaking, faculty) MOUNJARO · Diabetes | $1,400 |
| Lilly USA, LLC Nov 7, 2025 | Compensation for services other than consulting (speaking, faculty) MOUNJARO · Diabetes | $1,400 |
| Lilly USA, LLC Nov 7, 2025 | Compensation for services other than consulting (speaking, faculty) MOUNJARO · Diabetes | $1,400 |
| Lilly USA, LLC Oct 21, 2025 | Compensation for services other than consulting (speaking, faculty) MOUNJARO · Diabetes | $1,400 |
| Lilly USA, LLC Jun 27, 2025 | Compensation for services other than consulting (speaking, faculty) MOUNJARO · Diabetes | $1,400 |
All 80 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| Bayer HealthCare Pharmaceuticals Inc. Dec 20, 2025 | Travel and Lodging Kerendia · Cardio-Renal · travel to New Orleans, LA · in-kind | $1,144 |
| Lilly USA, LLC Nov 20, 2025 | Travel and Lodging MOUNJARO · Diabetes · travel to SAVANNAH, GA | $28.00 |
| Lilly USA, LLC Nov 20, 2025 | Travel and Lodging MOUNJARO · Diabetes · travel to SAVANNAH, GA | $11.76 |
| Lilly USA, LLC Nov 7, 2025 | Compensation for services other than consulting (speaking, faculty) MOUNJARO · Diabetes | $1,400 |
| Lilly USA, LLC Nov 7, 2025 | Compensation for services other than consulting (speaking, faculty) MOUNJARO · Diabetes | $1,400 |
| Lilly USA, LLC Nov 7, 2025 | Compensation for services other than consulting (speaking, faculty) MOUNJARO · Diabetes | $1,225 |
| Lilly USA, LLC Nov 5, 2025 | Travel and Lodging travel to SAVANNAH, GA · in-kind | $837 |
| Lilly USA, LLC Nov 5, 2025 | Travel and Lodging travel to SAVANNAH, GA · in-kind | $647 |
| Lilly USA, LLC Nov 5, 2025 | Travel and Lodging travel to SAVANNAH, GA · in-kind | $335 |
| Lilly USA, LLC Nov 5, 2025 | Travel and Lodging travel to SAVANNAH, GA · in-kind | $168 |
| Lilly USA, LLC Nov 5, 2025 | Travel and Lodging MOUNJARO · Diabetes · travel to GULFPORT, MS | $0.70 |
| Lilly USA, LLC Oct 31, 2025 | Travel and Lodging MOUNJARO · Diabetes · travel to GULFPORT, MS | $0.70 |
| Lilly USA, LLC Oct 23, 2025 | Compensation for services other than consulting (speaking, faculty) MOUNJARO · Diabetes | $1,400 |
| Lilly USA, LLC Oct 23, 2025 | Compensation for services other than consulting (speaking, faculty) MOUNJARO · Diabetes | $525 |
| Lilly USA, LLC Oct 23, 2025 | Travel and Lodging MOUNJARO · Diabetes · travel to GULFPORT, MS | $9.94 |
| Lilly USA, LLC Oct 21, 2025 | Compensation for services other than consulting (speaking, faculty) MOUNJARO · Diabetes | $1,400 |
| Lilly USA, LLC Oct 21, 2025 | Compensation for services other than consulting (speaking, faculty) MOUNJARO · Diabetes | $525 |
| Lilly USA, LLC Oct 17, 2025 | Compensation for services other than consulting (speaking, faculty) MOUNJARO · Diabetes | $1,400 |
| Lilly USA, LLC Oct 17, 2025 | Compensation for services other than consulting (speaking, faculty) MOUNJARO · Diabetes | $525 |
| Bayer HealthCare Pharmaceuticals Inc. Oct 17, 2025 | Travel and Lodging Kerendia · Cardio-Renal · travel to Aurora, CO · in-kind | $34.97 |
| Bayer HealthCare Pharmaceuticals Inc. Oct 17, 2025 | Travel and Lodging Kerendia · Cardio-Renal · travel to Aurora, CO · in-kind | $28.00 |
| Bayer HealthCare Pharmaceuticals Inc. Oct 8, 2025 | Compensation for services other than consulting (speaking, faculty) Kerendia · Cardio-Renal | $2,558 |
| Bayer HealthCare Pharmaceuticals Inc. Oct 8, 2025 | Compensation for services other than consulting (speaking, faculty) Kerendia · Cardio-Renal | $1,395 |
| Lilly USA, LLC Oct 8, 2025 | Travel and Lodging MOUNJARO · Diabetes · travel to WIGGINS, MS | $50.26 |
| Lilly USA, LLC Oct 3, 2025 | Compensation for services other than consulting (speaking, faculty) MOUNJARO · Diabetes | $1,400 |
| Lilly USA, LLC Oct 3, 2025 | Compensation for services other than consulting (speaking, faculty) MOUNJARO · Diabetes | $875 |
| Amgen Inc. Oct 1, 2025 | Travel and Lodging EVENITY · Bone Health · travel to Gulfport, MS | $13.44 |
| Amgen Inc. Sep 24, 2025 | Compensation for services other than consulting (speaking, faculty) EVENITY · Bone Health | $2,400 |
| Lilly USA, LLC Sep 24, 2025 | Travel and Lodging MOUNJARO · Diabetes · travel to BILOXI, MS | $19.60 |
| Lilly USA, LLC Sep 12, 2025 | Compensation for services other than consulting (speaking, faculty) MOUNJARO · Diabetes | $1,400 |
| Lilly USA, LLC Sep 12, 2025 | Compensation for services other than consulting (speaking, faculty) MOUNJARO · Diabetes | $525 |
| Lilly USA, LLC Aug 26, 2025 | Compensation for services other than consulting (speaking, faculty) MOUNJARO · Diabetes | $700 |
| Bayer HealthCare Pharmaceuticals Inc. Aug 17, 2025 | Travel and Lodging Kerendia · Cardio-Renal · travel to Aurora, CO · in-kind | $275 |
| Lilly USA, LLC Aug 15, 2025 | Compensation for services other than consulting (speaking, faculty) MOUNJARO · Diabetes | $700 |
| Lilly USA, LLC Jul 23, 2025 | Travel and Lodging MOUNJARO · Diabetes · travel to GULFPORT, MS | $7.70 |
| Lilly USA, LLC Jul 18, 2025 | Compensation for services other than consulting (speaking, faculty) MOUNJARO · Diabetes | $1,400 |
| Lilly USA, LLC Jul 18, 2025 | Compensation for services other than consulting (speaking, faculty) MOUNJARO · Diabetes | $525 |
| Bayer HealthCare Pharmaceuticals Inc. Jul 9, 2025 | Travel and Lodging Kerendia · Cardio-Renal · travel to Aurora, CO · in-kind | $22.10 |
| Lilly USA, LLC Jun 27, 2025 | Compensation for services other than consulting (speaking, faculty) MOUNJARO · Diabetes | $1,400 |
| Lilly USA, LLC Jun 27, 2025 | Compensation for services other than consulting (speaking, faculty) MOUNJARO · Diabetes | $1,400 |
| Lilly USA, LLC Jun 27, 2025 | Compensation for services other than consulting (speaking, faculty) MOUNJARO · Diabetes | $875 |
| Lilly USA, LLC Jun 24, 2025 | Travel and Lodging travel to COLUMBIA, MS · in-kind | $588 |
| Bayer HealthCare Pharmaceuticals Inc. Jun 19, 2025 | Travel and Lodging Kerendia · Cardio-Renal · travel to Aurora, CO · in-kind | $665 |
| Lilly USA, LLC Jun 4, 2025 | Travel and Lodging MOUNJARO · Diabetes · travel to BAY ST LOUIS, MS | $22.40 |
| Lilly USA, LLC Jun 2, 2025 | Compensation for services other than consulting (speaking, faculty) MOUNJARO · Diabetes | $1,400 |
| Lilly USA, LLC Jun 2, 2025 | Compensation for services other than consulting (speaking, faculty) MOUNJARO · Diabetes | $525 |
| Lilly USA, LLC May 23, 2025 | Compensation for services other than consulting (speaking, faculty) MOUNJARO · Diabetes | $1,400 |
| Lilly USA, LLC May 23, 2025 | Compensation for services other than consulting (speaking, faculty) MOUNJARO · Diabetes | $875 |
| Amgen Inc. May 21, 2025 | Travel and Lodging EVENITY · Bone Health · travel to Orlando, FL | $57.54 |
| Amgen Inc. May 21, 2025 | Travel and Lodging EVENITY · Bone Health · travel to Orlando, FL | $28.00 |
| Amgen Inc. May 21, 2025 | Travel and Lodging EVENITY · Bone Health · travel to Orlando, FL | $11.76 |
| Lilly USA, LLC May 20, 2025 | Travel and Lodging travel to BATON ROUGE, LA · in-kind | $685 |
| Amgen Inc. May 1, 2025 | Compensation for services other than consulting (speaking, faculty) EVENITY · Bone Health | $3,200 |
| Amgen Inc. May 1, 2025 | Compensation for services other than consulting (speaking, faculty) EVENITY · Bone Health | $1,200 |
| Lilly USA, LLC May 1, 2025 | Compensation for services other than consulting (speaking, faculty) MOUNJARO · Diabetes | $700 |
| Lilly USA, LLC Apr 30, 2025 | Compensation for services other than consulting (speaking, faculty) MOUNJARO · Diabetes | $700 |
| Lilly USA, LLC Apr 28, 2025 | Compensation for services other than consulting (speaking, faculty) MOUNJARO · Diabetes | $700 |
| Lilly USA, LLC Apr 25, 2025 | Compensation for services other than consulting (speaking, faculty) MOUNJARO · Diabetes | $700 |
| Lilly USA, LLC Apr 23, 2025 | Compensation for services other than consulting (speaking, faculty) MOUNJARO · Diabetes | $700 |
| Lilly USA, LLC Apr 17, 2025 | Compensation for services other than consulting (speaking, faculty) MOUNJARO · Diabetes | $700 |
| Amgen Inc. Apr 17, 2025 | Travel and Lodging EVENITY · Bone Health · travel to ORLANDO, FL · in-kind | $609 |
| Amgen Inc. Apr 17, 2025 | Travel and Lodging EVENITY · Bone Health · travel to ORLANDO, FL · in-kind | $313 |
| Lilly USA, LLC Apr 14, 2025 | Compensation for services other than consulting (speaking, faculty) MOUNJARO · Diabetes | $700 |
| Lilly USA, LLC Apr 14, 2025 | Compensation for services other than consulting (speaking, faculty) MOUNJARO · Diabetes | $700 |
| Lilly USA, LLC Apr 14, 2025 | Compensation for services other than consulting (speaking, faculty) MOUNJARO · Diabetes | $700 |
| Lilly USA, LLC Apr 10, 2025 | Compensation for services other than consulting (speaking, faculty) MOUNJARO · Diabetes | $700 |
| Lilly USA, LLC Apr 9, 2025 | Compensation for services other than consulting (speaking, faculty) MOUNJARO · Diabetes | $700 |
| Lilly USA, LLC Mar 31, 2025 | Travel and Lodging MOUNJARO · Diabetes · travel to SAUCIER, MS | $33.60 |
| Lilly USA, LLC Mar 24, 2025 | Compensation for services other than consulting (speaking, faculty) MOUNJARO · Diabetes | $1,400 |
| Lilly USA, LLC Mar 24, 2025 | Compensation for services other than consulting (speaking, faculty) MOUNJARO · Diabetes | $525 |
| Lilly USA, LLC Mar 14, 2025 | Compensation for services other than consulting (speaking, faculty) MOUNJARO · Diabetes | $700 |
| Neurocrine Biosciences, Inc. Mar 10, 2025 | Education CRENESSITY · Neuropsychiatry · in-kind | $24.04 |
| Bayer HealthCare Pharmaceuticals Inc. Feb 26, 2025 | Compensation for services other than consulting (speaking, faculty) Kerendia · Cardio-Renal | $698 |
| Amgen Inc. Feb 24, 2025 | Education in-kind | $7.96 |
| Amgen Inc. Feb 24, 2025 | Education in-kind | $7.96 |
| Lilly USA, LLC Feb 18, 2025 | Travel and Lodging MOUNJARO · Diabetes · travel to ATLANTA, GA | $28.00 |
| Lilly USA, LLC Feb 18, 2025 | Travel and Lodging MOUNJARO · Diabetes · travel to ATLANTA, GA | $12.88 |
| Lilly USA, LLC Feb 18, 2025 | Travel and Lodging MOUNJARO · Diabetes · travel to ATLANTA, GA | $3.00 |
| Lilly USA, LLC Feb 14, 2025 | Compensation for services other than consulting (speaking, faculty) MOUNJARO · Diabetes | $2,800 |
| Lilly USA, LLC Feb 6, 2025 | Travel and Lodging travel to ATLANTA, GA · in-kind | $497 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 4 industry-funded studies in 2025, from 3 companies. The companies reported $199,266 in research payments for these studies, mostly to the institutions running them.
- A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a)
Eli Lilly and Company · Active, not recruiting · NCT06292013 - A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity
Eli Lilly and Company · Active, not recruiting · NCT05556512 - A Phase 3, randomised, double-blind, parallel-group, event-driven, cardiovascular safety study with BI 456906 administered subcutaneously compared with placebo in participants with overweight or obesity with establish…
Boehringer Ingelheim Pharmaceuticals, Inc. - A Phase 3, randomised, double-blind, parallel-group, event-driven, cardiovascular safety study with BI 456906 administered subcutaneously compared with placebo in participants with overweight or obesity with establish…
Boehringer Ingelheim International GmbH
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.